ABSTRACT. Adipose tissue-derived mesenchymal stem cells (Ad-MSCs) are a promising source of cells for bone tissue engineering. Matrigel is a basement membrane extract containing multiple extracellular components. This mixture may promote the osteogenic differentiation of MSCs and provide a more appropriate microenvironment for transplanted cells. Here, we investigated the effect of Matrigel on the osteogenic potential of Ad-MSCs. Canine Ad-MSCs were cultured in 2D and 3D matrices and implanted into subcutaneous pouches of dogs either with or without Matrigel. Culture mineralization, cell adhesion efficiency, cell proliferation, osteoid matrix production and alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase activities were quantified and compared. Ad-MSCs grown in 2D cultures with Matrigel showed higher levels of calcium deposition and ALP activity than those grown in the absence of Matrigel under osteogenic conditions. In 3D cultures, the cells cultivated with Matrigel showed greater attachment, proliferation and osteogenic differentiation than those grown without Matrigel. In vivo, Ad-MSCs implanted with Matrigel showed higher osteogenic potential than those without Matrigel. In conclusion, these data suggest that the use of Matrigel can increase the osteogenic potential of canine Ad-MSCs.
Mesenchymal stem cells (MSCs) have recently received extensive attention as an attractive candidate for bone tissue regeneration due to their ability for indefinite selfrenewal and capability to differentiate into osteogenic lineages [10, 27, 29] . We have previously demonstrated that canine umbilical cord blood-derived MSCs mixed with beta-tricalcium phosphate (β-TCP) enhance bone formation in ectopic and orthotopic implantations of dogs [3, 11] . However, identification of other conditions and development of methods to control osteogenic differentiation of MSCs in vivo are required before these cells can be used for therapeutic purposes. Recently, several studies have shown that the interaction between stem cells and their surrounding microenvironments is critical for regulating stem cell behavior [22, 24, 34] .
The extracellular matrix (ECM) is a network of nonliving tissue that provides mechanical support to cells and is composed predominantly of major structural proteins including collagen, fibronectin and laminin [24] . The ECM is an essential element of the stem cell environment in vivo because these cells reside in a complex three-dimensional (3D) microenvironment in vivo, in which they constantly react to multiple types of signals [34] . In natural bone, osteocytes are evenly embedded in a mineralized ECM [9] . The ECM can also affect stem cell fate by mediating cell attachment and migration, presenting chemical and physical cues and binding soluble factors [34] . Hydrogels can be used as an ECM in tissue engineering procedures to facilitate new tissue formation in a 3D structure [28, 30] . Previous studies have demonstrated the ability of several types of hydrogels, including collagen, fibrin glue and alginate, to support the formation of new bone-like tissue using MSCs on β-TCP scaffolds in vitro and in vivo [6, 9, 32] .
Matrigel is a soluble and sterile extract of basement membrane proteins derived from Engelbreth-Holm-Swarm (EHS) mouse tumors [16] . Its primary component is laminin, followed by collagen IV, heparin sulfate proteoglycan, nidogen and entactin. This mixture also contains growth factors such as transforming growth factor-beta, fibroblast growth factor, epidermal growth factor, platelet-derived growth factor and insulin-like growth factor. Matrigel rapidly forms a 3D gel at 37°C and supports cell morphogenesis, differentiation and growth. Because Matrigel forms a 3D structure that is similar to an ECM, it may provide a more appropriate environment for tissue development or bone healing in vivo. Therefore, Matrigel might be considered to be a good hydrogel for promoting in vivo bone formation following stem cell transplantation. However, to our knowledge no studies have been performed to investigate the effect of Matrigel on the osteogenic potential of MSCs, although various combinations of cells and Matrigel have been used for tissue engineering in vivo.
In this study, adipose tissues were used as a cell source to obtain MSCs and confirm the osteogenic potential. Adipose tissue-derived MSCs (Ad-MSCs) have a good ability to differentiate into osteoblasts and to synthesize bone in β-TCP disks [10, 26] . Ad-MSCs also have clear advantages including easy and repeatable access to subcutaneous adipose tissue, simple isolation procedure, abundance in supply, and relatively noninvasive harvesting procedure [26] . These features might make Ad-MSCs suitable for cell therapies.
The purpose of the present study was to investigate the effect of Matrigel on the osteogenic potential of canine Ad-MSCs. For this investigation, we assessed the in vitro mineralization capability and alkaline phosphatase (ALP) activity of these cells grown on Matrigel-coated surfaces or polystyrene plastic surfaces using a 2D culture assay. We also evaluated the proliferation ability and osteogenic differentiation ability of the cells mixed with β-TCP granules using an in vitro 3D culture assay. Ectopic implantations were also used to compare the in vivo biocompatibility and osteogenic capability of Ad-MSCs with or without Matrigel. The in vivo effects of Matrigel were evaluated by histology, histomorphometry and ALP and tartrate-resistant acid phosphatase (TRACP) activities.
MATERIALS AND METHODS

Preparation of canine Ad-MSCs:
Canine Ad-MSCs were obtained by culturing to facilitate the proliferation of mononucleated cells from adipose tissues according to the methods described in our previous article [25] . Briefly, adipose tissues were aseptically collected from the gluteal region of a 2-year-old beagle dog under general anesthesia in order to isolate canine Ad-MSCs. The adipose tissues were extensively washed with phosphate buffered saline (PBS) and then minced with scissors. The minced tissues were digested with 1 mg/ml collagenase type I (Sigma-Aldrich, St. Louis, MO, U.S.A.) for 2 hr at 37°C. The tissue samples were washed with PBS and centrifuged at 200 g for 5 min. The resulting pellet of stromal vascular fraction was resuspended, filtered through a 100 µm nylon mesh and incubated overnight in Dulbecco's Modified Eagle's Medium (DMEM; Gibco, Billings, MT, U.S.A.) with 10% fetal bovine serum (FBS; Gibco) at 37°C in a 5% CO 2 humidified atmosphere. After 24 hr, unattached cells and residual nonadherent red blood cells were removed by washing with PBS. The medium was changed at 48-hr intervals until the cells became confluent. After cells reached 90% confluence, they were subcultured. At passage 3, these cells were used for in vitro osteogenic differentiation experiments and in vivo ectopic implantation.
In vitro 2D culture assay: Matrigel (Becton, Dickinson and Company, Franklin Lakes, NJ, U.S.A.) was diluted 1:3 with serum-free DMEM. To prepare the Matrigel-coated dishes, 200 µl of diluted Matrigel were added to each well of 12-well dishes and incubated at 37°C for 4 hr. Unbound Matrigel was aspirated from the wells, and the dishes were rinsed gently with serum-free medium.
Passage 3 Ad-MSCs were plated at a density of 5 × 10 4 cells per well in triplicate on either Matrigel-coated or uncoated surfaces of the 12-well plates and cultured in DMEM supplemented with 10% FBS (proliferation medium). When the cells had attained 70-80% confluence, the proliferation medium was replaced with osteogenic differentiation medium containing 0.1 µM dexamethasone (Sigma-Aldrich), 10 mM β-glycerophosphate (Sigma-Aldrich) and 50 µM ascorbic acid-2-phophate (Sigma-Aldrich) in DMEM with 10% FBS. The cells were maintained in culture for an additional 14 days at 37°C in 5% CO 2 , and the medium was replaced every 48 hr. Ad-MSCs cultured on a Matrigel-coated or uncoated culture plate with proliferation medium were used as controls. To compare the osteogenic differentiation of Ad-MSCs in 2D culture, mineralization and ALP activity were determined after 14 days of induction, and the mean values were statistically compared.
Alizarin Red S staining: To evaluate osteogenic differentiation of Ad-MSCs, Alizarin Red S staining was used to detect calcium deposition as previously described [23] . Briefly, the cells were stained with 40 mM Alizarin Red S (pH 4.2; Sigma-Aldrich) for 10 min at room temperature. Stained monolayers were observed by a light microscope (Nikon Corporation, Tokyo, Japan) at 100 × magnification. To quantitate the staining, the red matrix precipitate was dissolved using 100 mM cetylpyridinium chloride (SigmaAldrich) for 1 hr. The absorbance of the solubilized Alizarin Red S was measured at 570 nm using a spectrophotometer (SmartSpec TM 3000 Spectrometer, Bio-Rad, Hercules, CA, U.S.A.).
Preparation of beta-tricalcium phosphate (β-TCP): β-TCP granules were prepared using previously described methods by the Biomaterial Center, National Institute for Material Science, Tsukuba, Japan [14] .
In vitro 3D culture assay: First, 500 mg of β-TCP was added to 6-well polystyrene culture plates with a nylon mesh bottom insert (Becton, Dickinson and Company). Twentyfour hours before cell seeding, the granules were conditioned with 5 ml of serum-free proliferation medium and maintained at 37°C with 5% CO 2 . Then, 200 µl of Matrigel was mixed with 200 µl of DMEM, and a total of 2 × 10 5 cells in 400 µl of diluted Matrigel was seeded on 500 mg of β-TCP (n=12). To use as a control, 2 × 10 5 Ad-MSCs were simply suspended in 400 µl DMEM and seeded into β-TCP (n=12). After 3 hr of incubation with proliferation medium at 37°C and 5% CO 2 , the mesh insert containing the Ad-MSC-granule composite was transferred to another 6-well plate. This step allowed the separation of nonadherent cells (which passed through the mesh and adhered to the bottom of the wells of the plate) and the cells attached to β-TCP. To determine the number of cells that had not attached to the β-TCP particles, medium containing non-attached cells was collected, and the cells adhering to the bottom of the well were harvested with 0.25% trypsin-EDTA (Gibco). Cell counts were performed using a counting chamber (Marienfeld, Lauda-Königshofen, Germany). Finally, proliferation medium or osteogenic medium was added to the 6-well plates containing a mesh bottom insert to assess cell proliferation and osteogenic differentiation in the 3D cultures. The cultures were maintained for 14 days at 37°C in 5% CO 2 , and the medium was replaced every 48 hr. Cell viability was quantitatively determined by an MTT assay, and osteogenic differentiation was evaluated by measuring ALP activity.
MTT assay: Thiazolyl blue tetrazolium bromide (MTT; Sigma-Aldrich) was used to assess the viability and proliferation of the cells in 3D cultures at 3 and 14 days as previously described [20] . In brief, a 1 mg/ml MTT solution was added to each well, and the plates were incubated for 2 hr at 37°C. The MTT solution was removed, and 0.5 ml of dimethyl sulfoxide (Sigma-Aldrich) was added to dissolve the purple formazan crystals. The absorbance of this solution was quantified at 540 nm with a spectrophotometer.
Animals and in vivo ectopic implantations: Four healthy beagle dogs (average weight, 10.95 ± 0.96 kg) were used for the ectopic implantation experiments. All animal procedures were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of Seoul National University (SNU-100722-4). The dogs were sedated with an intravenous injection of acepromazine maleate (Sedaject, Samwoo Medical, Yesan, South Korea) at a dose of 0.02 mg/kg of body weight. Anesthesia then was induced by intravenous administration of 1% propofol (Provive 1%, Claris Lifesciences, Vasana, India) at a dose of 6 mg/ kg of body weight and maintained with isoflurane (Aerrane, Baxter, Mississauga, ON, Canada) in oxygen. Intravenously administered tramadol (Toranzin; Samsung Pharmaceutical, Seoul, South Korea) at a dose of 2 mg/kg of body weight was used as an analgesic.
There were four experimental groups: Implanted with 200 mg β-TCP mixed with 1 × 10 6 Ad-MSCs in 300 µl of Matrigel (Cell/Matrigel group), 200 mg β-TCP mixed with 1 × 10 6 Ad-MSCs in 300 µl of PBS (Cell group), 200 mg β-TCP mixed with 300 µl of Matrigel (Matrigel group) and 200 mg β-TCP mixed with 300 µl of PBS (Control group). Under sterile conditions, 12 paravertebral subcutaneous pouches were made in the back of each dog (1 × 1 cm, 5-cm distance), and mixed constructs were randomly implanted into these subcutaneous pouches under the skin (Fig. 1) . Each dog received 3 mixed materials per group at random, and thus one dog received a total of 12 implants. The implantation sites of each group were distributed evenly. Mixed constructs were fragile before implantation, and there were no differences in implant quality according to the presence of Matrigel. None of the dogs exhibited any adverse reactions to the implants during the experimental period.
The implants were harvested at 6 or 12 weeks postoperation. Five samples per group were resected after 6 weeks, and seven samples per group were harvested after 12 weeks. There were no macroscopic differences among experimental groups before and after implantation. Half of the samples were used for histological examinations, and the other half were used to make tissue lysates to measure ALP and TRACP activities.
Histological evaluation and histomorphometric analysis: The sample tissues were fixed in 4% paraformaldehyde for 1 day and then demineralized in a 10% ethylenediaminetetraacetic acid (Sigma-Aldrich) solution for 3 days at room temperature. After decalicification, the samples were dehydrated using a graded alcohol series and embedded in paraffin. Slices (5-µm thick) were mounted on silane-coated glass slides (Marienfeld). The sections were deparaffinized, hydrated and stained with hematoxylin and eosin (H&E). The stained slides were observed with light microscopy at 400 × magnification. For each implant, 10 sections underwent histomorphometric analysis. The areas of osteoid matrices and the residual β-TCP were measured at 12 weeks using the ImageJ software (National Institutes of Health, Bethesda, MD, U.S.A.), and the average percentages of the areas of osteoid and residual β-TCP relative to the total area of the microscopic fields were calculated.
Measurement of ALP and TRACP activities: ALP activity (which is recognized as an early osteoblastic marker) and TRACP activity (which is an osteoclastic marker) were measured. To investigate the ALP and TRACP activities of the osteogenic cultures and the implanted constructs, cells in the in vitro 2D or 3D cultures were homogenized with 300 or 500 µl of protein extraction solution (Invitrogen, Carlsbad, CA, U.S.A.); samples of the in vivo ectopic implants were crushed and homogenized with 600 µl of protein extraction solution. The cleared supernatant was collected after centrifugation at 16,000 g for 10 min at 4°C. The supernatant was assayed using a TRACP & ALP Assay Kit (Takara Bio Inc., Otsu, Shiga, Japan) according to the manufacturer's instructions. In brief, 50 µl of the cell lysate supernatant was mixed with 50 µl of the substrate solution (p-nitrophenyl phosphate substrate solution diluted in ALP buffer for ALP measurement or p-nitrophenyl phosphate substrate solution diluted in acid phosphatase buffer for TRACP measurement) and incubated at 37°C for 30 min. Stop solution (50 µl, 0.9 N NaOH) was added to each well, and the absorbance was measured at 405 nm with a spectrophotometer after color formation. Total protein content in aliquots of the same samples was determined using Bradford reagent (Sigma-Aldrich). The amount of ALP and TRACP activity was divided by the amount of total protein for normalization.
Statistical analysis: Statistical analysis was performed using SPSS version 18.0 (SPSS, Chicago, IL, U.S.A.). A Kruskal-Wallis test was used to assess differences among the groups. A post hoc test was performed along with a MannWhitney U test. A P-value less than 0.05 was considered to be statistically significant.
RESULTS
Osteogenic differentiation in 2D cultures: Significant mineralized depositions were observed in cultures of osteogenicinduced cells. No changes were detected in the control. Cells in the osteogenic medium were stained with Alizarin Red S after 2 weeks ( Fig. 2A and 2B ), but the cells grown in proliferative medium were not stained. Calcium deposition in the Matrigel-coated plates was significantly greater than that in polystyrene culture plates (P<0.05, Fig. 2C ).
The ALP activities of osteogenic-induced cells were significantly greater than those of the control (P<0.05, Fig.  2D ). ALP activity in the Matrigel cultures was significantly higher than that of cells cultured on uncoated plastic plates under osteogenic conditions (P<0.05, Fig. 2D) .
Cell adhesion and proliferation in 3D cultures: In order to determine whether the presence of Matrigel affects cell attachment, unattached cells were counted in the medium and the bottom of the wells following the 3-hr attachment phase. Cultures mixed with Matrigel had greater percentages of attached cells than those without Matrigel (P<0.05, Fig.  3A ). About 93% of the cells cultured with Matrigel attached to β-TCP, but only 57% of the cells cultured without Matrigel attached to β-TCP. These findings confirmed that the presence of Matrigel was associated with increased levels of cell attachment. Ad-MSCs in 3D cultures with Matrigel had higher levels of proliferation compared with cells grown without Matrigel (P<0.05, Fig. 3B ). The number of cells attached to β-TCP increased significantly over time in the presence of Matrigel after seeding, but the number of cells adhering to β-TCP did not increase over time in the absence of Matrigel.
Osteogenic differentiation in 3D cultures: ALP activity was detected at 14 days in osteogenic medium in Ad-MSCgranule constructs with or without Matrigel. ALP activity was significantly higher in constructs with Matrigel than without Matrigel (P<0.05, Fig. 3C ).
Histological evaluation and histomorphometric analysis: In the control and Matrigel groups implanted without AdMSCs, bone formation or resorption of β-TCP was not observed at 6 weeks, but the site of implantation was filled with fibrous tissue according to the histological sections stained with H&E (Fig. 4A) . However, penetration of osteoblastlike cells with osteoclast-like multinucleated giant cells and resorption of β-TCP were observed in the cell and cell/Matrigel groups. The osteogenic features were more pronounced at 12 weeks in the groups implanted with Ad-MSCs (cell/ Matrigel and cell groups) than in the other groups that received implants without cells. Osteoblasts were accumulated on the surface of the matrix-like bone layer, and osteocytes were located inside the osteoid matrix (Fig. 4B) . Osteoid formation also significantly increased at 12 weeks in the cell and cell/Matrigel groups (Fig. 4B) . Histomorphometric analysis of the tissue sections revealed the greatest osteoid matrix formation in the cell/ Matrigel group, followed by the cell group (Fig. 4C) . The osteoid matrix area was significantly different among the groups (P<0.05), with a 1.6-fold increase in relative osteoid formation in the cell/Matrigel group compared with the cell group. The residual β-TCP area in the groups implanted with Ad-MSCs was significantly decreased (P<0.05) compared with those in the groups implanted without cells (Fig. 4C) .
ALP and TRACP activities of the ectopic implanted constructs: At 6 weeks after implantation, the ALP activities in the cell and cell/Matrigel groups were significantly higher than those of the control and Matrigel groups (P<0.05, Fig. 5A ). ALP activity in the cell/Matrigel group increased rapidly and was significantly greater than those in the other groups at 12 weeks after implantation (P<0.05). The ALP activity in the cell group at 12 weeks after implantation was also greater than those in the control and Matrigel groups. TRACP activities increased gradually over time in all groups (Fig. 5B) . At 6 weeks after implantation, TRACP activity in the cell/Matrigel group was significantly higher than those in the other groups (P<0.05). TRACP activity in the cell/Matrigel group at 12 weeks after implantation was also higher than those in the control and Matrigel groups but not the cell group.
DISCUSSION
The main purpose of the present study was to evaluate the effect of Matrigel on the osteogenic potential of AdMSCs. First, the osteogenic potential of Ad-MSCs grown on Matrigel-coated culture dishes or uncoated dishes either in proliferation or differentiation media was assessed (Fig. 2) . No osteoblastic differentiation was observed during the experiment in cultures containing proliferation medium, while the high osteogenic potential was observed in cells grown in osteogenic differentiation medium. Interestingly, Ad-MSCs grown on Matrigel-coated surfaces in osteogenic medium showed higher levels of calcium deposition and ALP activity than the cells cultured on uncoated surfaces. These data demonstrated that Matrigel was capable of increasing osteogenic activity and matrix mineralization in vitro in the 2D cultures. However, our findings did not indicate that Matrigel was essential for bone formation or that Matrigel alone was the osteogenic stimulus for Ad-MSCs. The in vitro effects of Matrigel in 2D cultures suggest that Matrigel may affect osteogenic differentiation directly. Cells grown in in vivo or in vitro 3D environments might be exposed to a variety of factors that can possibly promote osteogenic differentiation. For example, 3D β-TCP scaffolds trigger the in vitro differentiation of MSCs toward an osteoblastic phenotype in the absence of differentiation media [19] . In the present study, we used an in vitro 2D culture assay lacking β-TCP to identify the direct role of Matrigel in promoting Ad-MSC osteogenic differentiation and confirmed that Matrigel increased the in vitro osteogenic differentiation of Ad-MSCs in 2D cultures (Fig. 2) .
We also used an in vitro 3D culture assay for osteogenic differentiation of Ad-MSCs because stem cells in vivo exist in a 3D environment. Data from this assay showed that AdMSCs seeded with Matrigel had higher levels of ALP activity compared with cells grown in the absence of Matrigel (Fig. 3) . Similar findings were also found in in vivo ectopic implants. Little bone formation was observed in implants unattached to β-TCP following a 3-hr incubation was measured, and the percentage of adherent cells was determined (A). Cell viability was quantified at 3 and 14 days using an MTT assay (B). ALP activity was measured at 14 days under osteogenic conditions (C). Adhesion analysis was carried out in sexuplicate. Measurements of proliferation and ALP activity were performed in triplicate. Bars represent the standard error of the mean. *Significant difference between two groups (P<0.05).
lacking Ad-MSCs (Fig. 4) . Quantitative analysis of in vivo osteogenic potential in the ectopic implants showed that the osteogenic potential of Ad-MSCs treated with Matrigel was significantly increased (Figs. 4, 5) . However, Matrigel alone did not have any significant effects in vivo (Figs. 4, 5) . Although the multiple responses that occurred between MSCs and Matrigel are not completely understood to date, increased osteogenic potential as measured by the in vitro and in vivo experiments performed in the present study can be explained by several direct or indirect possibilities. First, the ECM properties of Matrigel can promote the osteogenic differentiation of Ad-MSCs directly. The ECM provides cells with not only structural support but also biochemical and physical cues that regulate cell phenotype [22, 34] . Basement membrane components represent the first ECM synthesized in the developing embryo [16] . Because basement membranes represent the first extracellular matrix that comes into contact with stem cells, it would be expected that such matrices would exert profound effects on differentiation. Some studies have shown that Matrigel, as a complex ECM, can promote cellular differentiation in vitro [18, 31] . This biological activity of Matrigel can be explained by the abundance of components that promote differentiation via multiple classes of cell surface receptors [15, 35] . It is likely that cells interact with multiple components within the matrix to elicit the cellular responses observed. Most of the major components, such as laminin and/or collagen IV, interact via integrin receptors, which regulate the cellular cytoskeleton and cell behavior. A previous study described that both laminin and collagen IV, which were active com- ponents in Matrigel, influenced bone cell differentiation in vitro [31] . According to this report, rat primary calvarial bone cells and mouse osteoblast-like cells form isolated clusters that develop long interconnecting cell processes similar to canalicular networks observed in bone. Since cells contain and respond to receptors for more than one matrix component, multiple and synergistic interactions are needed for cell differentiation [15] . In addition, the various growth factors in Matrigel released when the matrix is degraded also regulate cell behavior [35] . Thus, cell differentiation may be more influenced by Matrigel, which contains multiple ECM components and growth factors, than individual components of the ECM such as laminin or collagen.
Matrigel might also affect cell adhesion and proliferation and thus enhance the osteogenic potential of Ad-MSCs indirectly. In the present study, the combination of β-TCP granules and Matrigel increased in vitro cell adhesion and proliferation in the 3D cultures as shown by the cell adhesion analysis and MTT assay (Fig. 3) . The initial cell seeding efficiency in the 3D cultures with Matrigel reached 93%, which was much higher than that of the 3D cultures lacking Matrigel. The number of cells attached to particles and the number of living cells were associated with the differences in osteogenic potential according to the presence of Matrigel. These results are likely due to the fact that Matrigel forms a strong clear gel that can hold the cells within the scaffold when warmed to 37°C. Furthermore, Matrigel contains cell adhesion molecules that provide binding sites for cell surface receptors [16, 34] . Previous studies have evaluated the effects of several hydrogels on the establishment of 3D cultures containing MSCs and β-TCP scaffolds and have shown that collagen gel is useful for bone tissue engineering [6, 33] . The cell adhesion rate in 3D cultures containing collagen is much lower than that of the Matrigel cultures used in the present study. Although it is difficult to compare the ability of Matrigel and collagen gel to promote the proliferation and osteogenesis of MSCs because of differences in experimental conditions, cells grown in Matrigel in the present study showed competitive proliferative and osteogenic potential compared with those maintained in collagen gel.
Matrigel may contribute to the survival of stem cells in vivo. Transplanted stem cells often undergo acute donor cell death or migrate away from the implantation areas in vivo [4] . This is likely due to the fact that implanted cells lack the physical and biochemical cues for their survival and adhesion. Therefore, a suitable biomaterial matrix capable of creating specialized microenvironments is necessary to improve stem cell survival and attachment in vivo. Cells in Matrigel containing multiple ECM components usually associate with one another under 3D conditions, become polarized and then form structures similar to those observed in their tissue of origin [16] . In the present study, the combination of Matrigel and Ad-MSCs allowed loose packing of β-TCP granules, thus promoting the even distribution of cells within the implants and enabling blood vessels to invade along the substrate. Matrigel also contains growth and angiogenic factors. These factors contribute to pro-growth and angiogenic signaling [5] . The effects of Matrigel are presumably related to the ability of this gel to promote angiogenesis and prevent cells from undergoing apoptosis. There is a special form of apoptosis that occurs when cells lose contact with the ECM [7] . This involves a decrease in signaling that results from the matrix molecules, such as laminin and/or collagen IV, binding to specific integrin receptors. These receptors activate focal adhesion kinase and initiate transcription of anti-apoptotic genes. Consequently, cell survival can primarily result from the cells' resistance to apoptosis rather than from activation of the growth factor response pathway. In a previous study, Matrigel was reported to have the potential of providing suitable matrices needed to increase stem cell survival [4] . Three common biomatrices (Matrigel, collagen and PuraMatrix) were evaluated, and it was found that Matrigel was superior to other matrices in terms of enhancing stem cell survival. Remarkably, Matrigel-supported stem cell survival was superior to survival of cells alone or cells supported with a collagen matrix. However, in vivo evaluation of implanted cell survival was lacking in the present study. Therefore, careful in vivo evaluation of the viability of implanted cells should be performed in future investigations. Finally, Matrigel can serve as a carrier of endogenous secreted growth factors or cytokines and prolong their releases in vivo. A previous study evaluated the effects of basic fibroblast growth factor (bFGF) suspended in Matrigel on implant fixation [8] . The results of that study found that the hydrophobic properties of Matrigel may maintain the controlled release of bFGF and help sustain the in vivo bioactivity of the bFGFs. In other words, the angiogenic potential of bFGFs suspended in Matrigel leads to the formation of new vessels and facilitates the transport of progenitor cells, thus creating an appropriate bone metabolic microenvironment at the site of implantation. A previous report from our laboratory demonstrated that canine umbilical cord blood-derived MSCs mixed with β-TCP improves bone regeneration in ectopic implants via the paracrine effects of the cells [3] . These findings suggested that a significant release of cytokines by MSCs at 1 day after implantation can enhance bone regeneration. In the present study, Matrigel might act as a carrier of growth factors or cytokines secreted by Ad-MSCs and thus can enhance the formation of osteoid matrix in vivo.
Despite these encouraging findings, some potential issues should be considered for the clinical use of Matrigel. The Matrigel used in this study is a product derived from the basement membrane of an EHS mouse sarcoma and contains a large number of different growth factors and extracellular matrix components of ill-defined composition. Thus, the possibility that Matrigel might have oncogenesis cannot be completely excluded, which can be a significant issue for its clinical application. However, to our knowledge, there have been no reports of Matrigel itself inducing tumors in vivo, although Matrigel has been used to promote in vivo survival or growth of tumor cells. Further studies are needed to transfer our experimental findings into a presumed subsequent clinical setting. In addition, there is also the possibility that a foreign-body reaction to Matrigel occurs in vivo. However, Matrigel has been used for tissue engineering in vivo without problems related with foreign-body reaction in several previous studies [1, 4, 8, 17, 21] . Besides, some reports have demonstrated that Matrigel promoted stem cell survival in vivo [1, 2, 4] . In the present study, no foreignbody reaction provoked by Matrigel was identified, although β-TCP constructs implanted into the subcutaneous pouch were encapsulated by fibrous tissues. The encapsulation of β-TCP by fibrous tissues was observed in all groups regardless of the presence of Matrigel or Ad-MSCs. This finding might be caused by fibrous tissues and vascular structures of host origin infiltrating into the β-TCP constructs implanted, and similar findings have been made with in vivo ectopic implantation by previous studies [3, 12, 13] .
In conclusion, the results from our study indicated that Matrigel can enhance the osteogenic potential and survival of Ad-MSCs. Matrigel may promote the osteogenic differentiation of stem cells directly or provide a more appropriate environment for bone healing indirectly. All these factors, in part or together, likely contribute to the observed changes in stem cell differentiation and tissue formation. Further studies on the mechanism underlying the effects of Matrigel and oncogenesis associated with in vivo application of Matrigel will show whether these experimental data can be translated into clinical applications.
